Skip to content
TrialScanner

NCT02907567

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Phase 1/Phase 2CompletedCGTXLead

Registry record

Lead sponsor
Cognition Therapeutics
Conditions
Alzheimer's Disease
Primary completion
Aug 24, 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02907567 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02907567: Clinical Trial of CT1812 in... | TrialScanner